MyFloralVault

Disclaimer: This content is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any herbal remedy or making changes to your health regimen. MyFloralVault does not claim that any plant cures, treats, or prevents any disease.

Maui True Blood Benefits & Medicinal Uses

Maui True Blood, a unique cultivar of Cannabis, is distinguished by its rich profile of cannabinoids, particularly THC (tetrahydrocannabinol) and CBD (cannabidiol), as well as terpenes like myrcene and limonene. This strain sits at the intersection of traditional herbal medicine, where cannabis has been used for centuries for pain and mood disorders, and cutting-edge research into the endocannabinoid system and its role in neuroprotection and inflammation. The synergy of its compounds is central to its effects, with ongoing studies exploring its potential in modulating the CB1 and CB2 receptors and beyond.

What it helps with

Chronic pain

THC, the primary psychoactive compound, binds to CB1 receptors in the central nervous system, modulating pain perception and reducing nociceptive signaling. Human trials show its efficacy in neuropathic pain, particularly when combined with CBD, which modulates CB2 receptors and reduces inflammation.

Anxiety & mood disorders

CBD exerts anxiolytic effects through 5-HT1A receptor agonism and modulation of GABAergic transmission. This results in reduced anxiety symptoms in both preclinical and small human studies, although the precise mechanisms and optimal dosing remain under investigation.

Inflammation & autoimmune conditions

Cannabinoids like CBD inhibit the NF-kB pathway, reducing pro-inflammatory cytokines such as TNF-alpha and IL-1beta. This mechanism is supported by animal models and early-phase human trials, particularly in conditions like rheumatoid arthritis and inflammatory bowel disease.

Neuroprotection & neurodegenerative diseases

Cannabinoids activate PPAR-gamma and exert antioxidant effects, reducing oxidative stress and neuroinflammation. Preclinical studies suggest potential benefits in Alzheimer's and Parkinson's disease, though human data are still emerging.

Epilepsy

CBD's anticonvulsant properties are mediated through modulation of ion channels and reduction of neuronal excitability. Its efficacy is well-documented in human trials, particularly for treatment-resistant epilepsy syndromes like Dravet syndrome.

Appetite stimulation & cachexia

THC stimulates appetite by activating CB1 receptors in the hypothalamus, influencing ghrelin and leptin signaling. This is particularly beneficial in conditions like cancer cachexia and AIDS-related wasting, as supported by clinical studies.

Sleep disorders

Cannabis, particularly strains high in myrcene, can modulate sleep patterns through CB1 receptor interaction and enhancement of GABAergic activity. While anecdotal evidence is strong, clinical trials are needed to clarify its role in sleep architecture.

Key active compounds

THC (Tetrahydrocannabinol)

The primary psychoactive cannabinoid. Binds to CB1 receptors, influencing pain, appetite, and mood. Its psychoactivity is a limitation in some therapeutic contexts.

CBD (Cannabidiol)

A non-psychoactive cannabinoid. Modulates CB2 receptors and influences serotonin and GABAergic systems, with broad anti-inflammatory and anxiolytic effects.

Myrcene

A monoterpene with sedative properties, enhances the permeability of cell membranes to cannabinoids, potentially increasing their effects.

Limonene

A terpene with mood-enhancing and anxiolytic properties, modulates serotonin receptors and may synergize with cannabinoids.

Beta-caryophyllene

A sesquiterpene that selectively binds to CB2 receptors, contributing to anti-inflammatory effects without psychoactivity.

Linalool

A terpene with calming properties, modulates glutamate and GABA neurotransmission, potentially enhancing anxiolytic effects.

Terpinolene

What the research says

Research on cannabis is expansive, with THC and CBD being the most studied compounds. THC's role in pain modulation and appetite stimulation is supported by robust human trials, while CBD's efficacy in epilepsy and anxiety is well-documented, though optimal formulations and dosages are still being refined. Preclinical studies highlight the neuroprotective potential of cannabinoids, but human trials are nascent. The main limitation remains the psychoactivity of THC and the variability of cannabinoid profiles between strains, which is addressed through selective breeding and the development of high-CBD, low-THC strains for therapeutic use.

Typical dosage

For smoking or vaporizing, start with a small amount (around 0.1-0.3 grams) and wait to assess effects before consuming more. For edibles, a common starting dose is 5-10 mg of THC, with effects taking up to 2 hours to manifest. Tinctures can be dosed at 2.5-5 mg of THC or CBD, held under the tongue for faster absorption. Topicals are applied directly to the skin as needed for localized relief.

Maui True Blood

Medicinal Facts

What it helps with

Chronic pain

Anxiety & mood disorders

Inflammation & autoimmune conditions

Neuroprotection & neurodegenerative diseases

Epilepsy

Appetite stimulation & cachexia

Sleep disorders

Key active compounds

What the research says

Typical dosage

Log in to view the Apothecary

About Maui True Blood

Traditional Use

Preparations & Dosage

Preparations

Interactions & Warnings

Use with caution

Herb Interactions

Community Plants

More in Mood & Emotional

Care guides for related plants

Explore by ailment

Log in to view the Apothecary